Progesterone Receptor Negative Active Not Recruiting Phase 2 Trials for Carboplatin (DB00958)

DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT01525966Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerTreatment
NCT00861705Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryTreatment